BeStock  
Stocks › Biotechnology › CRSP

CRISPR Therapeutics CRSP

$39.10 +$0.17 (+0.44%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.50 +1.02%
Open$38.18
Prev close$38.93
Day range$38.15 – $40.17
Volume3.32M
Market cap$3.79B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts12
Average target$74.27+89.9% vs. price
  • Buy 67%
  • Hold 33%
Low $50.00Now $39.10Avg $74.27High $110.00

Recent rating changes

The last 20 actions on file set price targets from $50.00 to $110.00, averaging $75.21.

DateFirmRatingTarget
10 Nov 2026 Needham BUY $82.00
10 Nov 2026 H.C. Wainwright BUY $80.00
9 Nov 2026 UBS HOLD $52.00
9 Nov 2026 Piper Sandler BUY $110.00
9 Nov 2026 Needham BUY $82.00
9 Nov 2026 H.C. Wainwright BUY $80.00
9 Nov 2026 J.P. Morgan BUY $67.00
8 Nov 2026 Citi BUY $90.00
4 Nov 2026 Wells Fargo HOLD $70.00
4 Nov 2026 BofA Securities BUY $80.00
4 Nov 2026 Citi BUY $90.00
4 Nov 2026 H.C. Wainwright BUY $80.00
3 Nov 2026 Wells Fargo HOLD $70.00
3 Nov 2026 UBS HOLD $52.00
3 Nov 2026 Piper Sandler BUY $110.00
3 Nov 2026 H.C. Wainwright BUY $80.00
3 Nov 2026 RBC Capital HOLD $50.00
3 Nov 2026 J.P. Morgan BUY –
15 Oct 2026 UBS HOLD $52.00
14 Oct 2026 UBS HOLD $52.00

Discussion

No comments yet — be the first to weigh in on CRSP.

Sign in to join the discussion.

Scroll to Top